Mammography-Based AI Breast Cancer Risk Prediction
Customize your policy alerts
Sign up for all premerabluecrossofwashington policy alerts
Know when premerabluecrossofwashington releases new policies or updates existing guidance.
Monitor payer policy activity
This policy addresses artificial intelligence software applied to bilateral screening mammograms to estimate an individual's five-year risk of developing breast cancer. The service is considered investigational and unproven because evidence is insufficient to establish improved health outcomes.
A new policy addresses mammography-based artificial intelligence risk prediction during bilateral screening mammography.
The policy establishes that mammography-based artificial intelligence risk prediction software used to estimate 5-year breast cancer risk is investigational.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.